Form 4: Zivo Bioscience Director Alison A. Cornell Reports Acquisition of 6,273 Shares
SEC Form 4 Filing
Director Alison A. Cornell reports acquiring 6,273 shares of Zivo Bioscience, Inc. common stock on June 11, 2024.
Summary
- On June 11, 2024, Alison A. Cornell, a director of Zivo Bioscience, Inc., acquired 6,273 shares of common stock.
- The acquisition was a direct transaction.
- Following the transaction, Cornell directly owns 245,985 shares of Zivo Bioscience, Inc.
Sentiment
Score: 5
Explanation: This is a neutral report of a transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects the director's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of transaction: Alison A. Cornell acquired 6,273 shares of Zivo Bioscience, Inc. common stock. |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Keywords
Zivo Bioscience, Insider Trading, Form 4, Director, Share Acquisition, Cornell, ZIVO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.